Patents expiring in 2032

US 8168678

N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8168604

Antisense antiviral compounds and methods for treating a filovirus infection

The United States of America as represented by the Army Medical Research and Material Command · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8168200

Vaccine against african horse sickness virus

The Regents of the University of California · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8168222

Amphiphilic polymer-protein conjugates and methods of use thereof

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8168202

Hexavalent bovine rotavirus reassortant composition designed for use in developing countries

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8168391

Method for modulating insulin production

The Regents of the University of California · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8168591

Compositions and methods related to anti-FGF agents

The Regents of the University of California · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8168626

Benzodiazepine compositions for treating epidermal hyperplasia and related disorders

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8168415

Axl fusion proteins as Axl tyrosine kinase inhibitors

The Regents of the University of Colorado · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8168636

Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

Rigel Pharmaceuticals, Inc. · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8168423

Device for detecting nitrosothiol content in solution

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8168775

Compositions and methods for inhibiting expression of transthyretin

Alnylam Pharmaceuticals, Inc. · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8168195

Vaccines against Escherichia coli O157 infection

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8168588

Compositions comprising FGF-9 and betacellulin and methods for treating cardiac conditions

Five Prime Therapeutics, Inc. · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8168754

Modified vitamin K-dependent polypeptides

Regents of the University of Minnesota · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8168776

Method for making a 21 nucleotide double stranded RNA chemically linked at one end

Alnylam Pharmaceuticals, Inc. · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8168800

Aβ-binding small molecules

The Regents of the University of California · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2446891

Semuloparin für Verwendung als eine antithrombotische Behandlung in den großen Bauchoperation mit verbesserter Sicherheit in Bezug auf klinisch relevante Blutungen und starken Blutungen

AVENTIS PHARMA SA [FR] · Granted Wed May 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Apr 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2446882

Arzneimittel mit dem Wirkstoff Hydromorphon mit verbesserter Lagerstabilität

ACINO PHARMA AG [CH] · Granted Wed May 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Apr 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2012055843

SÉMULOPARINE POUR LA PRÉVENTION D'UNE TROMBO-EMBOLIE VEINEUSE MAJEURE CHEZ UN PATIENT SUBISSANT UNE CHIRURGIE ABDOMINALE MAJEURE

AVENTIS PHARMA SA [FR] · Granted Thu May 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8173115

Particle compositions with a pre-selected cell internalization mode

The Board of Regents of the University of Texas System · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8173134

ECD carboxy-terminal deletion FGFR4 fusion proteins and methods of producing them

Five Prime Therapeutics, Inc. · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8173135

Methods for preparing complex multivalent immunogenic conjugates

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8173123

Methods of treating colitis involving IL-13 and NK-T cells

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8173362

Cytomegalovirus surface protein complex for use in vaccines and as a drug target

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8173602

Detecting CYP24 expression level as a marker for predisposition to cancer

The Regents of the University of California · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8173364

Methods and composition for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs

The Regents of the University of California · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8173392

In vivo incorporation of unnatural amino acids

The Regents of the University of California · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8173158

Methods of treating gastrointestinal disorders independent of the intake of food

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8173615

TRPM-2 antisense therapy

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8173360

Cell death inhibitor

Takeda Pharmaceutical Company Limited · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8173645

Glucokinase activators

Takeda San Diego, Inc. · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8173663

Dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8173628

Steroidal antiestrogens and antiandrogens and uses thereof

Northwestern University · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8173666

Oligomer-opioid agonist conjugates

Nektar Therapeutics · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8173673

Biofilm-inhibiting effect and anti-infective activity of N,C-linked aryl isoquinolines and the use thereof

Julius-Maximilians-Universitat Wurzburg · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8173815

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8173635

Kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8173664

Modified pyrimidine glucocorticoid receptor modulators

Corcept Therapeutics Incorporated · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8173139

High energy electron beam irradiation for the production of immunomodulators in poultry

The United States of America, as represented by the Secretary of Agriculture · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8173424

Internalizing ErbB2 antibodies

The Regents of the University of California · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8173120

Method of preventing reduced feed intake in animals and treatment of disease conditions

Precision Nutrition Pty Ltd · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8173133

Acyl pseudodipeptides which carry a functionalized auxiliary arm

OM PHARMA · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8178114

Patch device for a fragrance and method of using the patch device

Sentiv ApS · Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8178076

Diagnosis and assessment of skeletal related disease using calcium 41

The Regents of the University of California · Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8178109

Compositions and methods of use for MGD-CSF in disease treatment

Five Prime Therapeutics, Inc. · Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8178298

Patched polypeptides and uses related thereto

The Regents of the University of California · Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8178531

Antiviral agents

Enanta Pharmaceuticals, Inc. · Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)